YAP and TAZ Heterogeneity in Primary Liver Cancer: An Analysis of Its Prognostic and Diagnostic Role
Primary liver cancer comprises a diverse group of liver tumors. The heterogeneity of these tumors is seen as one of the obstacles to finding an effective therapy. The Hippo pathway, with its downstream transcriptional co-activator Yes-associated protein (YAP) and transcriptional co-activator with PD...
Guardado en:
Autores principales: | Matthias Van Haele, Iván M. Moya, Ruçhan Karaman, Guy Rens, J. Snoeck, Olivier Govaere, Frederik Nevens, Chris Verslype, Baki Topal, Diethard Monbaliu, Georg Halder, Tania Roskams |
---|---|
Formato: | Artigo |
Lenguaje: | inglés |
Publicado: |
2019
|
Acceso en línea: | https://doi.org/10.3390/ijms20030638 https://www.mdpi.com/1422-0067/20/3/638/pdf?version=1549024629 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
YAP and TAZ Heterogeneity in Primary Liver Cancer: An Analysis of Its Prognostic and Diagnostic Role
por: Van Haele, Matthias, et al.
Publicado: (2019) -
Peritumoral activation of the Hippo pathway effectors YAP and TAZ suppresses liver cancer in mice
por: Iván M. Moya, et al.
Publicado: (2019) -
High‐throughput sequencing identifies aetiology‐dependent differences in ductular reaction in human chronic liver disease
por: Olivier Govaere, et al.
Publicado: (2018) -
The PDGFRα-laminin B1-keratin 19 cascade drives tumor progression at the invasive front of human hepatocellular carcinoma
por: Olivier Govaere, et al.
Publicado: (2017) -
Human Liver Regeneration: An Etiology Dependent Process
por: Van Haele, Matthias, et al.
Publicado: (2019)